Table 1.
Hemodynamic Parameters in RHC and Results of PFTs and Laboratory Tests.
| On admission | On the treatment | One month after the treatment | Seven months after the treatment | ||
|---|---|---|---|---|---|
| RHC | mPAP (mmHg) | 31 | 28 | 28 | 24 |
| PAWP (mmHg) | 6 | 13 | 9 | 13 | |
| CO (L/min) | 5.89 | 3.93 | 2.99 | 4.55 | |
| PVR (dyn/s/cm5) | 390 | 385 | 508 | 193 | |
| PFTs | %VC | 44.7 | 55 | 72.4 | |
| %FVC | 47 | 57.5 | 73.9 | ||
| %FEV1 | 88.6 | 93.2 | 87.1 | ||
| %DLCO | 31.7 | 48 | 51.3 | ||
| %FVC/%DLCO | 1.48 | 1.20 | 1.44 | ||
| Laboratory | KL-6 (U/mL) | 3,861 | 3,111 | 3,058 | 1,443 |
| tests | BNP (pg/mL) | 310 | 181 | 90 | 21 |
| NYHA classification | IV | III | II | I | |
| 6MWT (m/6min) | 451 | ||||
RHC: right heart catheterization, PFTs: pulmonary function tests, NYHA: New York heart association, 6MWT: 6-minute walk test, mPAP: mean pulmonary artery pressure, PAWP: pulmonary arterial wedge pressure, CO: cardiac output (Fick method), PVR: pulmonary vascular resistance, VC: vital capacity, FVC: forced vital capacity, FEV1: forced expiratory volume in 1 second, DLCO: diffusing capacity for carbon monoxide, KL-6: Krebs von den Lungen-6 , BNP: brain natriuretic peptide